Back Bio

Michele N. Washington, Ph.D.

Michele N. Washington, Ph.D.

Associate| Phoenix


Michele Washington focuses her practice on the preparation and prosecution of patent applications in the life sciences. Her experience covers a wide range of technologies, including cellular and molecular biology, biochemistry, biological therapies, antibody technology, immunotherapy, agriculture biotechnology, and medical devices. Michele’s specific experience includes prosecuting worldwide patent portfolios; and performing freedom to operate, patentability and invalidity analyses.

Michele is licensed to practice only in Colorado and before the United States Patent and Trademark Office. 

  • University of Denver, Sturm College of Law (J.D., 2014)
    • Irving P. Andrews Award for Outstanding Law Graduate
  • Baylor College of Medicine, Graduate School of Biomedical Sciences (Ph.D., Department of Molecular and Cellular Biology, 2010)
    • Dissertation: "Targets of Vitamin D Receptor Action in Prostate Cancer Cells"
  • The Colorado College (B.A., Biology, 2003)
    • Minor in Spanish
  • American Intellectual Property Law Association
  • Colorado Intellectual Property American Inn of Court
  • Sam Cary Bar Association
  • Colorado Women’s Bar Association
  • "ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts," Co-Author, 2015 Cell Death and Disease 6, e1836 (2015)
  • "Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy," Co-Author, 2011 Cancer 117(19):4424-38 (2011)
  • "1a,25-Dihydroxyvitamin D3 Inhibits C4-2 Prostate Cancer Cell Growth via a Retinoblastoma Protein (Rb)-Independent G1 Arrest," Co-Author, 2010 The Prostate 71(1):98-110 (2010)
  • "1a,25-Dihydroxyvitamin D3 Inhibits Growth of VCaP Prostate Cancer Cells Despite Iducing the Growth-Promoting TMPRSS2:ERG Gene Fusion," Co-Author, 2010 Endocrinology 151(4):1409-1417 (2010)
  • "Xenobiotic Stress Induces Hepatomegaly and Liver Tumors via the Nuclear Receptor Constitutive Androstane Receptor," Co-Author, 2005 Molecular Endocrinology 19(6):1646-1653 (2005)
  • "Sulindac Sulfide Inhibits Epidermal Growth Factor-inducted Phosphorylation of Extracellular-regulated Kinase 1/2 and Bad in Human Colon Cancer Cells," Co-Author, 2003 Cancer Research 63:616-620 (2003)
  • Lathrop Gage LLP, Associate (2014-2018), Summer Associate (2013)
  • National Renewable Energy Laboratory, Extern (2013)
  • McElroy, Deutsch, Mulvaney & Carpenter, LLP, Summer Associate (2012)
  • University of Texas M.D. Anderson Cancer Center, Post-Doctoral Fellow, Department of Experimental Therapeutics (2010-2011)
  • Colorado
  • United States Patent and Trademark Office
  • Supreme Court of Colorado